Nimrit Goraya, MD Reference List
|
|
- Magdalene Fox
- 6 years ago
- Views:
Transcription
1 Book Chapter Goraya N, Wesson DE: Chapter Title The Physiology of the Metabolic Acidosis of Chronic Kidney Disease (CKD). Book title Metabolic Acidosis: A Guide to Clinical Assessment and Management 2016 Goraya N, Wesson DE: Chapter Title, Overview of Acid-Base Physiology. Book title Metabolic Acidosis: A Guide to Clinical Assessment and Management 2016 Presentation Goraya N, Simoni J, Kitzman-Ulrich H, Wesson D Treatment of Metabolic Acidosis in Chronic Kidney Disease with Fruits and Vegetables Improves Cardiovascular Risk Poster and paper presentations at 38th Annual Meeting & Scientific Sessions, Society of Behavioral Medicine, April 1, 2017, San Diego CA 2017 Goraya N, Pruszynski J, Simoni J, Wesson D The Course of Acid Retention without Metabolic Acidosis as GFR Declines in CKD Abstract Oral Presentation at American Society of Nephrology 2015 Kidney Week, November 2015, San Diego CA 2015 Goraya N, Wesson D (2011) Dietary Acid Reduction with Added Fruits & Vegetables or Oral Bicarbonate Preserves GFR in Subjects with CKD Stage 4 GFR. ASN Kidney Week 2011 oral presentation, Philadelphia PA 2011 Nimrit Goraya, Donald Wesson (2011) Hypertensives with CKD have higher dietary acid due to lower intake of fruits and vegetables. SSCI oral presentation, New Orleans LA August 19,
2 Presentation Nimrit Goraya, Mohanram Narayanan, Gregory Jaffers (2009). Posttransplant lymphoproliferative disorder Plasmablastic lymphoma in renal transplant patients Oral presentation TTS, San Antonio TX Publications Goraya N, Wesson DE (2016) Dietary Protein as Kidney Protection: Quality or Quantity? J Am Soc Nephrol 2016 Jul;27(7): Goraya N, Wesson DE (2016) Is Dietary Red Meat Kidney Toxic? J Am Soc Nephrol 28: 2016 Epublished before print, August 22, Goraya N, Wesson DE (2015) Dietary Interventions to Improve Outcomes in Chronic Kidney Disease Current Opinion in Nephrology and Hypertension 2015 Nov;24(6): Goraya N, Wesson DE (2014) Is Dietary Acid a Modifiable Risk Factor for Nephropathy Progression? Am J Nephrol 2014;39(2): Goraya N, Simoni J, Jo CH, Wesson DE (2014) Treatment of Metabolic Acidosis in Patients with Stage 3 Chronic Kidney Disease with Fruits and Vegetables or Oral Bicarbonate Reduces Urine Angiotensinogen and Preserves Glomerular Filtrate Rate. Kidney International 2014 Nov;86(5): August 19,
3 Publications Goraya N, Wesson DE (2013) Does Correction of Metabolic Acidosis Slow Chronic Kidney Disease Progression? Curr Opin Nephrol Hypertens 2013 Mar;22(2): Goraya N, Simoni J, Jo CH, Wesson DE (2013) A Comparison of Treating Metabolic Acidosis in CKD Stage 4 Hypertensive Kidney Disease with Fruits and Vegetables or Sodium Bicarbonate Clin J Am Soc Nephrol 2013 Mar;8(3): Goraya N, Wesson D (2012) Acid-base Status and Progression of Chronic Kidney Disease (CKD) Current Opinion in Nephrology and Hypertension 2012 Sep;21(5): Goraya N, Simoni J, Jo C, Wesson DE (2012) Dietary Acid Reduction with Fruits and Vegetables or Bicarboate Attenuates Kidney Injury in Patients with a Moderately Reduced Glomerular Filtration Rate Due to Hypertensive Nephropathy Kidney International 2012 Jan;81(1: Wesson D, Goraya N (2012) Dietary Management of Chronic Kidney Disease (CKD): Protein Restriction and Beyond Current Opinion in Nephrology and Hypertension 2012 Nov;21(6): Jadvinder Goraya, Nimrit Goraya, J. David Faichney (2006). Proteinuria secondary to lipoprotein glomerulopathy (LPG) in Apolipoprotein (apo) E3/E4 variant successfully treated with fenofibrate. ACP Poster Presentation, Traverse City MI August 19,
4 Poster Presentation Goraya N, Simoni J, Kitzman-Ulrich H, Wesson D Treatment of Metabolic Acidosis in Chronic Kidney Disease with Fruits and Vegetables Improves Cardiovascular Risk Poster and paper presentations at 38th Annual Meeting & Scientific Sessions, Society of Behavioral Medicine, April 1, 2017, San Diego CA 2017 Goraya N, Simoni J, Pruszynski J, Madias N, Wesson Urine Citrate Excretion Might Identify Eubicarbonatemic CKD Patients with Acid Retention and Assess their Response to Therapy Poster presentation at American Society of Nephrology Kidney Week 2016 Annual Meeting, November 18, 2016, Chicago IL 2016 Goraya N, Simoni J, Pruszynski J, Xiana P, Wesson DE Blood Pressure Control Is Better and Less Expensive in Chronic Kidney Disease when Associated Metabolic Acidosis is Treated with Fruits and Vegetables Rather than Sodium Bicarbonate Poster Presentation at American Heart Association Council on Hypertension 2016 Scientific Sessions, September 15, 2016, Orlando FL 2016 AlBaalbaki F, Goraya N, Munshi N Scleroderma Renal Crisis: More Evidence of Angiotensin Converting Enzyme Inhibitors Superiority over Angiotensin-Receptor Blockers Poster, NKF 2015 Spring Clinical Meetings, Dallas TX. Am J Kidney Dis 2015;65(4):A Nimrit Goraya, Donald Wesson (2011). Dietary Fruits and Vegetables Reduce Augmented Urine Endothelin and Aldosterone Excretion Associated with Reduced GFR. SSCI Poster presentation, New Orleans LA Biresh Kumar, Nimrit Goraya, Donald Wesson (2010). A lower acidinducing diet lowers augmented kidney endothelin production associated with reduced GFR. SSCI poster presentation, New Orleans LA. J of Investigative Medicine, Feb (58(2); August 19,
5 Poster Presentation Nimrit Goraya, Biresh Kumar, Donald Wesson (2010). A lower acid inducing diet lowers augmented acid retention associated with reduced GFR. SSCI poster presentation, New Orleans LA. J of Investigative Medicine, Feb 2010, 58(2); Nimrit Goraya, J Simoni, K Broglio, Donald Wesson (2010) Adding dietary fruits and vegetables reduces kidney injury in subjects with moderately reduced GFR. ASN Poster presentation, Denver CO J Am Soc Nephrol 21:2010;646A Nimrit Goraya, Mohanram Narayanan, Luis Concepcion (2010) Prediction of cardiovascular disease during pre-transplant evaluation. ASN Poster presentation, Denver CO. J Am Soc Nephrol 21:2010;329A Nimrit Goraya, Mohanram Narayanan, Gregory Jaffers (2009). BK PVAN in the setting of positive viruria in the absence of viremia. ATS Poster presentation, Boston MA Nimrit Goraya, Mohanram Narayanan, et al (2009) Biopsy proven BK polyoma nephropathy in the presence of viruria and lack of viremia Nimrit Goraya, Jadvinder Goraya, J David Faichney (2007). Central Diabetes Insipidus secondary to Mefloquine. ACP Poster Presentation, East Lansing MI August 19,
6 Poster Presentation Erika Woolley, Nimrit Goraya, Timothy Fritz (2005) Pseudoaneurysm An accessory head. Poster Presentation, MSU-GRMERC Research Day, Grand Rapids MI August 19,
BASELINE CHARACTERISTICS OF THE STUDY POPULATION
COMPARISON OF TREATING METABOLIC ACIDOSIS IN CKD STAGE 4 HYPERTENSIVE KIDNEY DISEASE WITH FRUITS & VEGETABLES OR SODIUM BICARBONATE This was a 1-year, single-center, prospective, randomized, interventional
More informationBASELINE CHARACTERISTICS OF THE STUDY POPULATION
Study Summary DAILY ORAL SODIUM BICARBONATE PRESERVES GLOMERULAR FILTRATION RATE BY SLOWING ITS DECLINE IN EARLY HYPERTENSIVE NEPHROPATHY This was a 5-year, single-center, prospective, randomized, placebo-controlled,
More informationMohanram Narayanan MD, FACP, FASN, FNKF,FRCP (C) Reference List Abstract
Abstract Primary Hyperoxaluria Causing ESRD and Lower Extremity Gangrene 662 Nidhi Munshi, Mohanram Narayanan 66E Abstract and Poster presented at the Annual Dialysis Conference March, Orlando, FL. 2008
More informationStudy of association of serum bicarbonate levels with mortality in chronic kidney disease
International Journal of Research in Medical Sciences Kumar S et al. Int J Res Med Sci. 2016 Nov;4(11):4852-4856 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20163779
More informationImportant aspects of acid-base disorders
Important aspects of acid-base disorders I. David Weiner, M.D. Co-holder, C. Craig and Audrae Tisher Chair in Nephrology Division of Nephrology, Hypertension and Transplantation University of Florida College
More informationALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)
1 RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) 6 / 5 / 1006-1 2 Introduction Hypertension is the second most common cause of end-stage
More informationNimrit Goraya 1,2, Jan Simoni 3, Chanhee Jo 4 and Donald E. Wesson 1,4. original article. see commentary on page 7
original article http://www.kidney-international.org & 2012 International Society of Nephrology see commentary on page 7 Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney
More informationHHS Public Access Author manuscript Kidney Int. Author manuscript; available in PMC 2016 January 01.
The Balance of the Evidence on Acid-Base Homeostasis and Progression of CKD Julia J. Scialla, MD, MHS 1,2 1 Division of Nephrology, Duke University School of Medicine, Durham, NC 2 Duke Clinical Research
More informationVolume 9 Issue 1 April, Role of Low Acid Diet In Chronic Kidney Disease
A REVIEW International Journal of Medical Sciences DOI : 10.15740/HAS/IJMS/9.1/37-42 Volume 9 Issue 1 April, 2016 37-42 e ISSN-0976-7932 Visit us - www.researchjournal.co.in Role of Low Acid Diet In Chronic
More informationObjectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives
The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA
More informationNew aspects of acid-base disorders
New aspects of acid-base disorders I. David Weiner, M.D. C. Craig and Audrae Tisher Chair in Nephrology Division of Nephrology, Hypertension and Transplantation University of Florida College of Medicine
More informationThe Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009
The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 Teresa Northcutt, RN BSN Primaris Program Manager, Prevention - CKD MO-09-01-CKD This material was prepared by Primaris,
More informationNimrit Goraya 1, Jan Simoni 2, Chan-Hee Jo 3 and Donald E. Wesson 1. clinical investigation
http://www.kidney-international.org & 2014 International Society of Nephrology clinical investigation Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables
More informationSpecial Challenges and Co-Morbidities
Special Challenges and Co-Morbidities Renal Disease/ Hypertension/ Diabetes in African-Americans M. Keith Rawlings, MD Medical Director Peabody Health Center AIDS Arms, Inc Dallas, TX Chair, Internal Medicine
More informationVA/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care (2008) PROVIDER REFERENCE CARDS Chronic Kidney Disease
VA/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care (2008) PROVIDER REFERECE CARDS Chronic Kidney Disease CKD VA/DoD Clinical Practice Guideline for the Management
More informationHYPERTENSION IN CKD. LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL
HYPERTENSION IN CKD LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL Stages in Progression of Chronic Kidney Disease and Therapeutic Strategies Complications Normal Increased risk Damage GFR
More informationSLOWING PROGRESSION OF KIDNEY DISEASE. Mark Rosenberg MD University of Minnesota
SLOWING PROGRESSION OF KIDNEY DISEASE Mark Rosenberg MD University of Minnesota OUTLINE 1. Epidemiology of progression 2. Therapy to slow progression a. Blood Pressure control b. Renin-angiotensin-aldosterone
More informationChronic Kidney Disease. Basics of CKD Terms Diagnosis Management
Chronic Kidney Disease Basics of CKD Terms Diagnosis Management Review the prevalence of chronic kidney disease (CKD) Review how CKD develops Review populations at risk for CKD Review CKD diagnosis Objectives
More informationClaudio Bazzi, 1 Elena Tagliabue, 2 Sara Raimondi, 2 Virginia Rizza, 3 Daniela Casellato, 4 and Masaomi Nangaku Introduction
Hindawi Publishing Corporation International Journal of Nephrology Volume 2015, Article ID 730234, 7 pages http://dx.doi.org/10.1155/2015/730234 Clinical Study High ( 6.5) Spontaneous and Persistent Urinary
More informationPatient Description and Diagnosis: Sarah Jones is a 50-year-old female, 5 4, 131
Julia Kaesberg Counseling Session KNH 413 February 27 th, 2014 Patient Description and Diagnosis: Sarah Jones is a 50-year-old female, 5 4, 131 pounds and her usual body weight is 125 pounds. Her %UBW
More informationDIABETES AND YOUR KIDNEYS
DIABETES AND YOUR KIDNEYS OR AS WE CALL IT DIABETIC NEPHROPATHY The latest guidelines to keep you safe, healthy, fit, and out of danger from needing dialysis A UCLA HEALTH EDUCATIONAL SEMINAR Ramy M. Hanna
More informationReducing proteinuria
Date written: May 2005 Final submission: October 2005 Author: Adrian Gillin Reducing proteinuria GUIDELINES a. The beneficial effect of treatment regimens that include angiotensinconverting enzyme inhibitors
More informationInterventions to reduce progression of CKD what is the evidence? John Feehally
Interventions to reduce progression of CKD what is the evidence? John Feehally Interventions to reduce progression of CKD what is the evidence? CHALLENGES Understanding what we know. NOT.what we think
More informationDonald E. Wesson. Editor. Metabolic Acidosis. A Guide to Clinical Assessment and Management
Metabolic Acidosis Donald E. Wesson Editor Metabolic Acidosis A Guide to Clinical Assessment and Management Editor Donald E. Wesson, MD, MBA Baylor Scott and White Health Department of Internal Medicine
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Specific effects of calcium channel blockers in diabetic nephropathy GUIDELINES
Specific effects of calcium channel blockers in diabetic nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. Non-dihydropyridine calcium channel
More informationSGLT2 inhibition in diabetes: extending from glycaemic control to renal and cardiovascular protection
SGLT2 inhibition in diabetes: extending from glycaemic control to renal and cardiovascular protection Hiddo Lambers Heerspink Department of Clinical Pharmacy and Pharmacology University Medical Center
More informationMANAGEMENT CALL TO DISCUSS LONGER-TERM IMPROVEMENTS IN KIDNEY FUNCTION WITH BARDOXOLONE
MANAGEMENT CALL TO DISCUSS LONGER-TERM IMPROVEMENTS IN KIDNEY FUNCTION WITH BARDOXOLONE Introduction Substantial body of prior CKD clinical data characterizes Bard s unique profile Bard has demonstrated
More informationOutpatient Management of Chronic Kidney Disease for the Internist
Outpatient Management of Chronic Kidney Disease for the Internist Annual Meeting of Maryland Chapter of the American College of Physicians February 3, 2018 MARY (TESSIE) BEHRENS, MD, FACP, FASN, FNKF MID-ATLANTIC
More informationAngiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) To STOP OR Not in Advanced Renal Disease
Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) To STOP OR Not in Advanced Renal Disease Investigator Meeting 12 th September 2017 - Sheffield Prof Sunil Bhandari Consultant
More informationACE Inhibitors and Protection Against Kidney Disease Progression in Patients With Type 2 Diabetes: What s the Evidence?
Reviews ACE Inhibitors and Protection Against Kidney Disease Progression in Patients With Type 2 Diabetes: What s the Evidence? George L. Bakris, MD; 1 and Matthew Weir, MD 2 Although angiotensin-converting
More informationDaily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy
http://www.kidney-international.org & 2010 International Society of Nephrology Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy
More informationManagement of early chronic kidney disease
Management of early chronic kidney disease GREENLANE SUMMER GP SYMPOSIUM 2018 Jonathan Hsiao Renal and General Physician Introduction A growing public health problem in NZ and throughout the world. Unknown
More informationHypertension and diabetic nephropathy
Hypertension and diabetic nephropathy Elisabeth R. Mathiesen Professor, Chief Physician, Dr sci Dep. Of Endocrinology Rigshospitalet, University of Copenhagen Denmark Hypertension Brain Eye Heart Kidney
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. ACE Inhibitor and Angiotensin II Antagonist Combination Treatment GUIDELINES
ACE Inhibitor and Angiotensin II Antagonist Combination Treatment Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES No recommendations possible based on Level
More informationPrognosis in CKD Can we do anything about it? Rodney D Gilbert
Prognosis in CKD Can we do anything about it? Rodney D Gilbert A diagnosis of end stage renal failure implies what degree of loss of life expectancy? A. 10% B. 20% C. 30% D. 40% E. 50% F. 60% 38% 22% 16%
More informationDr. Liliana Garneata Assistant Professor of Nephrology Dr Carol Davila Teaching Hospital of Nephrology, Bucharest, Romania
Dr. Liliana Garneata Assistant Professor of Nephrology Dr Carol Davila Teaching Hospital of Nephrology, Bucharest, Romania Nutritional management of CKD: Key-role of ketoanalogues with low protein diets
More informationStages of Chronic Kidney Disease (CKD)
Early Treatment is the Key Stages of Chronic Kidney Disease (CKD) Stage Description GFR (ml/min/1.73 m 2 ) >90 1 Kidney damage with normal or GFR 2 Mild decrease in GFR 60-89 3 Moderate decrease in GFR
More informationClinical Pearls in Renal Medicine
Clinical Pearls in Renal Medicine Joel A. Gordon MD Professor of Medicine Nephrology Division Staff Physician Kidney Disease and Blood Pressure Clinic Disclosures None of my financial holdings will have
More informationACEIs / ARBs NDHP dihydropyridine ( DHP ) ACEIs ARBs ACEIs ARBs NDHP. ( GFR ) 60 ml/min/1.73m ( chronic kidney disease, CKD )
005 16 175-180 1 1 ( chronic kidney disease, CKD ) 003 ( end-stage renal disease, ESRD ) Angiotensin-converting enzyme inhibitors ( ) angiotensin receptor blockers ( ) nondihydropyridine ( NDHP ) / NDHP
More informationManagement of Hypertensive Chronic Kidney Disease: Role of Calcium Channel Blockers. Robert D. Toto, MD
R e v i e w P a p e r Management of Hypertensive Chronic Kidney Disease: Role of Calcium Channel Blockers Robert D. Toto, MD Both the prevalence and incidence of end-stage renal disease have been increasing
More informationFabry Disease and the Kidneys
Department of Human Genetics Division of Medical Genetics Lysosomal Storage Disease Center www.genetics.emory.edu Fabry Disease and the Kidneys What is Fabry Disease? Fabry disease (FD) is an X-linked
More informationProceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009
www.ivis.org Proceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009 São Paulo, Brazil - 2009 Next WSAVA Congress : Reprinted in IVIS with the permission of the Congress Organizers PROTEINURIA
More informationDiabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin
Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin Disclosures I have no financial relationship with the manufacturers of any commercial product discussed during this
More information5 Easy Steps to Optimize Your GFR, Creatinine, and BUN Levels
1 Understand your lab test numbers and learn how to improve them with these 5 amazing tips! Check out the e-book Renal Progress: A Kidney Patient s Guide to Improving Kidney Function Test Results, also
More informationQUICK REFERENCE FOR HEALTHCARE PROVIDERS
KEY MESSAGES 1 SCREENING CRITERIA Screen: Patients with DM and/or hypertension at least yearly. Consider screening patients with: Age >65 years old Family history of stage 5 CKD or hereditary kidney disease
More informationNa + /K + interaction in the kidney, blood vessels, brain, and beyond
Na + /K + interaction in the kidney, blood vessels, brain, and beyond Horacio J. Adrogué, M.D. Professor of Medicine, Baylor College of Medicine Chief, Clinical Nephrology and Hypertension. Houston Methodist
More informationHot Topics in Diabetic Kidney Disease a primary care perspective
Hot Topics in Diabetic Kidney Disease a primary care perspective DR SARAH DAVIES GP PARTNER WITH SPECIAL INTEREST IN DIABETES, CARDIFF DUK CLINICAL CHAMPION NB MEDICAL HOT TOPICS PRESENTER AND DIABETES
More informationJefferies Healthcare Conference June 6, 2018
Jefferies Healthcare Conference June 6, 2018 Forward-Looking Statements Some of the statements included in this presentation, particularly those regarding the commercialization and ongoing clinical development
More informationChronic Kidney Disease
Chronic Kidney Disease Presence of kidney damage or decreased kidney function for three or more months, - necessary to distinguish CKD from acute kidney disease. Ascertained either by kidney biopsy or
More informationCase Studies: Renal and Urologic Impairments Workshop
Case Studies: Renal and Urologic Impairments Workshop Justine Lee, MD, DBIM New York Life Insurance Co. Gina Guzman, MD, DBIM, FALU, ALMI Munich Re AAIM Triennial October, 2012 The Company You Keep 1 Case
More informationDonald E. Wesson 1 and Jan Simoni 2. original article. see commentary on page 1065
original article http://www.kidney-international.org & 21 International Society of Nephrology see commentary on page 165 Acid retention during kidney failure induces endothelin and aldosterone production
More informationThe Seventh Report of the Joint National Commission
The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow-up of the Modification of Diet in Renal Disease Study Mark J. Sarnak, MD; Tom Greene, PhD; Xuelei Wang,
More informationChronic Kidney Disease
Chronic Kidney Disease Chronic Kidney Disease (CKD) Educational Objectives Outline Demographics Propose Strategies to slow progression and improve outcomes Plan for treatment of CKD Chronic Kidney Disease
More informationCardiovascular Pharmacotherapy in Special Population: Cardio-Nephrology
49 th Annual Scientific Meeting The Heart Association of Thailand under the Royal Patronage of H.M. the King Cardiology on the move 24-25 March 2017 @Sheraton, HuaHin Cardiovascular Pharmacotherapy in
More informationSection Questions Answers
Section Questions Answers Guide to CKD Screening and Evaluation -Alec Otteman, MD Delaying Progression - Paul Drawz, MD, MHS, MS 1. Modifiable risk factors for CKD include: a. Diabetes b. Hypertension
More informationIrish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012
Irish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012 Susan McKenna Renal Clinical Nurse Specialist Cavan General Hospital Renal patient population ACUTE RENAL FAILURE
More informationFaculty. Disclosures. Learning Objectives. Definitions. Definitions (cont) The Role of the Kidney in Cardiometabolic Disease
Faculty The Role of the Kidney in Cardiometabolic Disease Christian W. Mende, MD, FACP, FACN, FASN, FASH Clinical Professor of Medicine University of California at San Diego San Diego, California Disclosures
More informationChronic Kidney Disease An Update
Chronic Kidney Disease An Update Background: The Duval County Medical Society (DCMS) is proud to provide its members with free continuing medical education (CME) opportunities in subject areas mandated
More informationCYNTHIA M. KROEGER EDUCATION ACADEMIC AND RESEARCH APPOINTMENTS
EDUCATION Postdoctoral Fellow Obesity Research Methods Statistics University of Alabama at Birmingham School of Public Health August 2015 Present Supervisor: David B. Allison, Ph.D. F32 Project title:
More informationMasatoshi Kawashima 1, Koji Wada 2, Hiroshi Ohta 2, Rika Moriya 3 and Yoshiharu Aizawa 1. Journal of Occupational Health
176 J Occup Health, Vol. 54, 2012 J Occup Health 2012; 54: 176 180 Journal of Occupational Health Evaluation of Validity of the Urine Dipstick Test for Identification of Reduced Glomerular Filtration Rate
More informationDIABETES AND CHRONIC KIDNEY DISEASE
DIABETES AND CHRONIC KIDNEY DISEASE Stages 1 4 www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney Foundation's Kidney Disease Outcomes
More informationThe Western Diet: Are We Killing Our Patients. Holly Kramer, MD, MPH Loyola Medical Center Maywood, IL
The Western Diet: Are We Killing Our Patients Holly Kramer, MD, MPH Loyola Medical Center Maywood, IL Let food be thy medicine Hippocrates Westernization Clothing Diet Entertainment Language Social engagement
More informationHYPERTENSION GUIDELINES WHERE ARE WE IN 2014
HYPERTENSION GUIDELINES WHERE ARE WE IN 2014 Donald J. DiPette MD FACP Special Assistant to the Provost for Health Affairs Distinguished Health Sciences Professor University of South Carolina University
More informationCURRICULUM VITAE Kidney Council New Investigator Award, American Heart Association (AHA)
CURRICULUM VITAE Name: Shengyu MU Business Address: Room303, BIOMED I, University of Arkansas for Medical Science. 4301 W Markham St. Little Rock, AR72205. USA. Contact E-mail: smu@uams.edu or mushengyu218@gmail.com
More informationNet endogenous acid production is associated with a faster decline in GFR in African Americans
http://www.kidney-international.org & 2012 International Society of Nephrology Net endogenous acid production is associated with a faster decline in GFR in African Americans Julia J. Scialla 1, Lawrence
More informationDiabetes and kidney disease.
Diabetes and kidney disease. What are the implications? Can it be prevented? Nice 18 june 2010 Lars G Weiss. M.D. Ph.D. Department of Neprology Central Hospital Karlstad Sweden Diabetic nephropathy vs
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Membranous nephropathy role of steroids GUIDELINES
Membranous nephropathy role of steroids Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES There is currently no data to support the use of short-term courses of
More informationKidney Disease, Hypertension and Cardiovascular Risk
1 Kidney Disease, Hypertension and Cardiovascular Risk George Bakris, MD, FAHA, FASN Professor of Medicine Director, Hypertensive Diseases Unit The University of Chicago-Pritzker School of Medicine Chicago,
More informationProf. Andrzej Wiecek Department of Nephrology, Endocrinology and Metabolic Diseases Medical University of Silesia Katowice, Poland.
What could be the role of renal denervation in chronic kidney disease? Andrzej Wiecek, Katowice, Poland Chairs: Peter J. Blankestijn, Utrecht, The Netherlands Jonathan Moss, Glasgow, UK Prof. Andrzej Wiecek
More informationClinical Commissioning Policy: Rituximab for the treatment of idiopathic membranous nephropathy in adults
Clinical Commissioning Policy: Rituximab for the treatment of idiopathic membranous nephropathy in adults Reference: NHS England: 16047/P NHS England INFORMATION READER BOX Directorate Medical Operations
More informationChronic Kidney Disease for the Primary Care Physician in What do the Kidneys do? CKD in the US
1:25-2:25pm Managing Chronic Kidney Disease in 2019 SPEAKERS Adriana Dejman, MD Chronic Kidney Disease for the Primary Care Physician in 2019 Adriana Dejman, MD Assistant Professor of Clinical Medicine
More informationCase Presentation Turki Al-Hussain, MD
Case Presentation Turki Al-Hussain, MD Director, Renal Pathology Chapter Saudi Society of Nephrology & Transplantation Consultant Nephropathologist & Urological Pathologist Department of Pathology & Laboratory
More informationCKD FOR INTERNISTS. Dr Ahmed Hossain Associate professor Medicine Sir Salimullah Medical College
CKD FOR INTERNISTS Dr Ahmed Hossain Associate professor Medicine Sir Salimullah Medical College INTRODUCTION In 2002, the National Kidney Foundation s Kidney Disease Outcomes Quality Initiative(KDOQI)
More informationDiabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin
Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin Disclosures I have no financial relationship with the manufacturers of any commercial product discussed during this
More informationUpdated guidelines for managing chronic kidney disease Darlene Dobkowski, MS, PA-C; Kim Zuber, PA-C, DFAAPA; Jane Davis, DNP
Updated guidelines for managing chronic kidney disease Darlene Dobkowski, MS, PA-C; Kim Zuber, PA-C, DFAAPA; Jane Davis, DNP ABSTRACT Chronic kidney disease (CKD) is the most costly disease covered by
More informationChronic kidney disease in cats
Chronic kidney disease in cats What is chronic kidney disease (CKD)? Chronic kidney disease (CKD) is the name now used to refer to cats with kidney failure (or chronic kidney failure). CKD is one of the
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. 5. Classification of chronic kidney disease based on evaluation of kidney function
5. Classification of chronic kidney disease based on evaluation of kidney function Date written: April 2005 Final submission: May 2005 GUIDELINES No recommendations possible based on Level I or II evidence
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic kidney disease: early identification and management of adults with chronic kidney disease in primary and secondary
More informationVA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005
VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,
More informationCase Study in Chronic Renal Failure
Case Study in Chronic Renal Failure Development of Knowledge Base: There were over 14,500 articles dealing with chronic renal failure entered into PubMed during 2000 2004. A current concept in this array
More informationEast London Community Kidney Service
East London Community Kidney Service Sally Hull, Neil Ashman, Sec Hoong, Nicola Thomas, Helen Rainey April 2017 Haemodialysis/million population What is the Problem? Fast rising ESRD rates in East London
More informationSalt Sensitivity: Mechanisms, Diagnosis, and Clinical Relevance
Salt Sensitivity: Mechanisms, Diagnosis, and Clinical Relevance Matthew R. Weir, MD Professor and Director Division of Nephrology University of Maryland School of Medicine Overview Introduction Mechanisms
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Protein Restriction to prevent the progression of diabetic nephropathy GUIDELINES
Protein Restriction to prevent the progression of diabetic nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. A small volume of evidence suggests
More informationVolume Management 2/25/2017. Disclosures statement: Objectives. To discuss evaluation of hypervolemia in peritoneal dialysis patients
Volume Management Sagar Nigwekar MD, MMSc Massachusetts General Hospital E-mail: snigwekar@mgh.harvard.edu March 14, 2017 Disclosures statement: Consultant: Allena, Becker Professional Education Grant
More informationDr. Mehmet Kanbay Department of Medicine Division of Nephrology Istanbul Medeniyet University School of Medicine Istanbul, Turkey.
The uric acid dilemma: causal risk factor for hypertension and CKD or mere bystander? Mehmet Kanbay, Istanbul, Turkey Chairs: Anton H. van den Meiracker, Rotterdam, The Netherlands Claudia R.C. Van Roeyen,
More informationManaging High Blood Pressure Naturally. Michael A. Smith, MD Life Extension s Healthy Talk Series
Managing High Blood Pressure Naturally Michael A. Smith, MD Life Extension s Healthy Talk Series Part 1 What is Blood Pressure? Blood Pressure Systole Systolic Forward Pressure 110 mmhg 70 mmhg Diastole
More informationChronic kidney disease screening and assessment
Care map information Information resources for patients and carers Aboriginal and Torres Strait Islanders DEFINITION OF CKD egfr
More information014 Chapter 14 Created: 9:25:14 PM CST
014 Chapter 14 Created: 9:25:14 PM CST Student: 1. Functions of the kidneys include A. the regulation of body salt and water balance. B. hydrogen ion homeostasis. C. the regulation of blood glucose concentration.
More informationPredicting and changing the future for people with CKD
Predicting and changing the future for people with CKD I. David Weiner, M.D. Co-holder, C. Craig and Audrae Tisher Chair in Nephrology Professor of Medicine and Physiology and Functional Genomics University
More informationClinical Study Synopsis
Clinical Study Synopsis This file is posted on the Bayer HealthCare Clinical Trials Registry and Results website or on the website www.clinicalstudyresults.org hosted by the Pharmaceutical Research and
More informationhyperlipidemia in CKD DR MOJGAN MORTAZAVI ASSOCIATE PROFESSOR OF NEPHROLOGY ISFAHAN KIDNEY DISEASES RESEARCH CENTER
Management of hyperlipidemia in CKD DR MOJGAN MORTAZAVI ASSOCIATE PROFESSOR OF NEPHROLOGY ISFAHAN KIDNEY DISEASES RESEARCH CENTER Background on Dyslipidemia in CKD In advanced chronic kidney disease (CKD),
More informationEvidence-based practice in nephrology : Meta-analysis
Evidence-based practice in nephrology : Meta-analysis Paweena Susantitaphong, MD,Ph.D 1-3 1 Associate Professor, Division of Nephrology, Department of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn
More informationBicarbonate therapy for prevention of chronic kidney disease progression
http://www.kidney-international.org & 2013 International Society of Nephrology Bicarbonate therapy for prevention of chronic kidney disease progression Igor Łoniewski 1 and Donald E. Wesson 2,3 1 Sanum
More informationDiscovery & Validation of Kidney Injury Biomarkers
Dublin Academic Medical Centre Discovery & Validation of Kidney Injury Biomarkers Patrick Murray, MD, FASN, FRCPI, FJFICMI Professor, University College Dublin, Mater Misericordiae University Hospital,
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Specific management of IgA nephropathy: role of fish oil
Specific management of IgA nephropathy: role of fish oil Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES Early and prolonged treatment with fish oil may retard
More informationCardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center
Cardiovascular Disease in CKD Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Objectives Describe prevalence for cardiovascular disease in CKD
More informationObesity and Chronic Kidney. The Catholic University of Korea Cheol Whee Park, M.D.
Obesity and Chronic Kidney Disease The Catholic University of Korea Cheol Whee Park, M.D. Epidemic Obesity and type 2 Diabetes in Asia Yoon KH, et al. Lancet 368:1681-1688, 2006 [1 단계 ] 지방세포가커진다 [2 단계
More informationPRIMARY PHASE 2 ANALYSES FROM CARDINAL: A PHASE 2/3 STUDY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME
PRIMARY PHASE 2 ANALYSES FROM CARDINAL: A PHASE 2/3 STUDY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME 217 American Society of Nephrology Meeting Geoffrey A. Block 1, Pablo E. Pergola 2, Lesley
More information